Credit Agricole’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.31M | Sell |
42,663
-14,463
| -25% | -$3M | 0.02% | 542 |
|
|
2026
Q1 | $12.8M | Sell |
57,126
-20,772
| -27% | -$5.18M | 0.03% | 342 |
|
|
2025
Q4 | $18.8M | Buy |
77,898
+1,499
| +2% | +$383K | 0.04% | 300 |
|
|
2025
Q3 | $20.9M | Buy |
+76,399
| New | +$20.9M | 0.06% | 248 |
|
|
2025
Q1 | $17.5M | Buy |
78,293
+2,812
| +4% | +$656K | 0.06% | 268 |
|
|
2024
Q4 | $17.3M | Buy |
75,481
+31,709
| +72% | +$7.63M | 0.05% | 274 |
|
|
2024
Q3 | $10.7M | Buy |
43,772
+8,801
| +25% | +$1.97M | 0.05% | 275 |
|
|
2024
Q2 | $6.69M | Buy |
34,971
+26,036
| +291% | +$5.28M | 0.04% | 308 |
|
|
2024
Q1 | $1.59M | Buy |
8,935
+4,773
| +115% | +$875K | 0.02% | 447 |
|
|
2023
Q4 | $716K | Buy |
4,162
+2,779
| +201% | +$427K | 0.01% | 492 |
|
|
2023
Q3 | $205K | Buy |
+1,383
| New | +$250K | ﹤0.01% | 572 |
|
|
2017
Q4 | – | Sell |
-67,581
| Closed | -$5.2M | – | 925 |
|
|
2017
Q3 | $5.2M | Sell |
67,581
-59,547
| -47% | -$4.56M | 0.02% | 646 |
|
|
2017
Q2 | $9.9M | Sell |
127,128
-1,404
| -1% | -$100K | 0.03% | 501 |
|
|
2017
Q1 | $9.25M | Buy |
128,532
+25,398
| +25% | +$1.76M | 0.03% | 573 |
|
|
2016
Q4 | $6.4M | Buy |
103,134
+22,395
| +28% | +$1.37M | 0.02% | 624 |
|
|
2016
Q3 | $5.23M | Buy |
80,739
+16,938
| +27% | +$1.13M | 0.02% | 681 |
|
|
2016
Q2 | $4.03M | Buy |
63,801
+41
| +0.1% | +$2.42K | 0.02% | 669 |
|
|
2016
Q1 | $3.69M | Sell |
63,760
-33,957
| -35% | -$1.92M | 0.02% | 642 |
|
|
2015
Q4 | $5.25M | Sell |
97,717
-48,061
| -33% | -$2.71M | 0.02% | 548 |
|
|
2015
Q3 | $7.43M | Sell |
145,778
-21,900
| -13% | -$1.18M | 0.04% | 459 |
|
|
2015
Q2 | $9.45M | Buy |
167,678
+26,567
| +19% | +$1.68M | 0.04% | 424 |
|
|
2015
Q1 | $10.1M | Buy |
141,111
+71,611
| +103% | +$4.65M | 0.05% | 420 |
|
|
2014
Q4 | $3.96M | Buy |
69,500
+49,000
| +239% | +$2.56M | 0.02% | 707 |
|
|
2014
Q3 | $1.01M | Sell |
20,500
-4,100
| -17% | -$209K | ﹤0.01% | 1083 |
|
|
2014
Q2 | $1.25M | Sell |
24,600
-1,200
| -5% | -$59.5K | 0.01% | 1066 |
|
|
2014
Q1 | $1.15M | Buy |
25,800
+5,984
| +30% | +$269K | ﹤0.01% | 982 |
|
|
2013
Q4 | $933K | Buy |
19,816
+4,516
| +30% | +$229K | ﹤0.01% | 1056 |
|
|
2013
Q3 | $808K | Buy |
+15,300
| New | +$742K | ﹤0.01% | 1077 |
|
Other funds holding RMD
Credit Agricole's RMD Position: Q2 2026 in Review
Credit Agricole reduced its ResMed (RMD) stake by 25% in Q2 2026, selling an estimated $3M and leaving 42,663 shares worth $8.31M. The position accounts for 0.02% of the portfolio, ranked #542.
Credit Agricole first reported a position in RMD in Q3 2013 and has held it in 28 quarters since. The position peaked at $20.9M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Credit Agricole held 42,663 shares of ResMed worth $8.31M as of Q2 2026.
- Credit Agricole sold 14,463 ResMed shares in Q2 2026, an estimated $3M.
- ResMed made up 0.02% of Credit Agricole's portfolio in Q2 2026, its #542 holding.
- Credit Agricole first reported a position in ResMed in Q3 2013 and has held it in 28 quarters since.
- Credit Agricole's ResMed position peaked at $20.9M in Q3 2025.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.